Physicochemical characterization of a peptide deriving from the glycoprotein gp36 of the feline immunodeficiency virus and its lipoylated analogue in micellar systems.
P59 is the Trp-rich 20-mer peptide ((767)L-G(786)), partial sequence of the membrane-proximal external region (MPER) of the FIV gp36. It has potent antiviral activity, possibly due to a mechanism that inhibits the fusion of the virus with the cell membranes. In the hypothesis that a lipophilic tail could enhance the adhesion of P59 to the membrane so improving its antiviral activity, we synthesized its lipoylated analogue lipo-P59. Fluorescence, CD and NMR investigations in membrane mimicking environments (such as SDS and DPC micelles) were aimed to assess the potential of the lipo-P59 lipophilic tail to affect the biophysical and conformational behaviour of the peptide. In vitro inhibitory assays using lymphoid cell cultures to check the antiviral activity of peptides were also performed. The data show that the biophysical properties and the conformational preferences of the peptides are not dramatically affected by the hydrophobic tail, suggesting that the lipopeptide is capable of preserving all the biophysical peculiarities. Similarly, antiviral experimental data show that the membrane-anchored lipo-P59 peptide is also effective in inhibiting virus replication. Moreover, the lipophilic tail allows P59 to preserve its antiviral activity even in conditions in which the non lipoylated peptide is devoid of activity. In accordance with the unusual high Trp presence, the peptides confirm the preference to be positioned on the membrane interface. Furthermore, the data point out a peculiarity of interaction of the peptides with SDS as compared with DPC.
Esposito
Cinzia
C
Dipartimento di Scienze Farmaceutiche, Università di Salerno, Fisciano, Italy.
D'Errico
Gerardino
G
Armenante
Maria Rosaria
MR
Giannecchini
Simone
S
Bendinelli
Mauro
M
Rovero
Paolo
P
D'Ursi
Anna M
AM
D000998:Antiviral Agents / Q000494:pharmacology; D002942:Circular Dichroism; D004058:Diffusion; D004578:Electron Spin Resonance Spectroscopy; D006023:Glycoproteins / Q000737:chemistry* / Q000494:pharmacology; D016089:Immunodeficiency Virus, Feline / Q000187:drug effects; D008074:Lipoproteins / Q000737:chemistry*; D008823:Micelles; D019906:Nuclear Magnetic Resonance, Biomolecular; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000737:chemistry; D011487:Protein Conformation; D012967:Sodium Dodecyl Sulfate / Q000737:chemistry; D013050:Spectrometry, Fluorescence; D014759:Viral Envelope Proteins / Q000737:chemistry* / Q000494:pharmacology
D000998:Antiviral Agents; D006023:Glycoproteins; D008074:Lipoproteins; D008823:Micelles; D014759:Viral Envelope Proteins; D010767:Phosphorylcholine; D012967:Sodium Dodecyl Sulfate; C028810:dodecylphosphocholine